Finabase

    • Login
    • Categories
    Home Watchlists Portfolios Map Forex Futures Crypto Comparisons Alerts Screeners Backtests vTrading Settings Forum
    1. Home
    2. BCRX
    • Alert
    • Note
    BCRX
    BioCryst Pharmaceuticals, Inc.
    9.10
    +
    0.07
    0.78%
    12 x 9.00
    14 x 9.12
    bid
    ask
    13 @ 04:00 PM
    9.15+0.05 (0.55%)
    Bearish 28
    Bullish 78
    sentiment
    8.68
    day range
    9.20
    7.89
    52 week range
    19.76
    04:00 PM
    V: 3.20M
    C: 9.10
    L: 8.68
    H: 9.20
    O: 9.11
    loading chart ...
    • 1d
    • 5d
    • 1m
    • 3m
    • 6m
    • ytd
    • 1y
    • 2y
    • 5y
    • max
    • PDF
    • Full Chart
    • Stats
    • Watchlist
    • Portfolio
    Prev Close9.03
    Open9.11
    Low8.68
    High9.20
    Volume3.20M
    Avg. Volume4.95M
    Market Cap1.69B
    Inst. Own71.76%
    Beta2.51
    Short Ratio4.76
    Div & Yield0.00 /
    EPS-1.07
    P/E
    1yr Target17.45
    50day MA12.47
    200day MA14.12
    ^DJI
    Dow Jones Industrial Average
    31261.90
    05:03 PM
    +
    8.80
    0.03%
    ^IXIC
    NASDAQ Composite
    11354.60
    05:15 PM
    -
    33.90
    0.30%
    ^GSPC
    S&P 500
    3901.36
    05:03 PM
    +
    0.57
    0.01%
    AAPL
    137.58
    -0.01 (0.01%)
    Apple Inc.
    137.59
    11 @ 04:00 PM
    13 x 137.56
    8 x 137.60
    +
    0.24
    0.17%
    GOOG
    2187.00
    +0.74 (0.03%)
    Alphabet Inc.
    2186.26
    9 @ 04:00 PM
    10 x 2186.26
    8 x 2186.00
    -
    28.65
    1.29%
    AMZN
    2159.37
    +7.55 (0.35%)
    Amazon.com, Inc.
    2151.82
    10 @ 04:00 PM
    8 x 2157.85
    12 x 2165.00
    +
    5.44
    0.25%
    MSFT
    252.94
    +0.38 (0.15%)
    Microsoft Corporation
    252.56
    9 @ 04:00 PM
    9 x 252.80
    8 x 253.00
    -
    0.58
    0.23%
    FB
    193.81
    +0.27 (0.14%)
    Meta Platforms, Inc.
    193.54
    10 @ 04:00 PM
    8 x 193.50
    11 x 193.55
    +
    2.25
    1.18%
    BABA
    86.97
    +0.18 (0.21%)
    Alibaba Group Holding Limited
    86.79
    10 @ 04:01 PM
    12 x 86.82
    8 x 86.98
    -
    0.90
    1.03%
    NFLX
    186.80
    +0.45 (0.24%)
    Netflix, Inc.
    186.35
    22 @ 04:00 PM
    13 x 186.50
    31 x 186.13
    +
    2.87
    1.56%
    TSLA
    665.40
    +1.50 (0.23%)
    Tesla, Inc.
    663.90
    9 @ 04:00 PM
    8 x 665.30
    10 x 665.40
    -
    45.52
    6.42%
    NVDA
    166.94
    +0.00 (0.00%)
    NVIDIA Corporation
    166.94
    10 @ 04:00 PM
    8 x 166.85
    11 x 166.97
    -
    4.30
    2.51%
    AMD
    93.46
    -0.04 (0.04%)
    Advanced Micro Devices, Inc.
    93.50
    9 @ 04:00 PM
    9 x 93.54
    8 x 93.53
    -
    3.17
    3.28%
    MU
    68.60
    -0.30 (0.44%)
    Micron Technology, Inc.
    68.90
    11 @ 04:00 PM
    11 x 68.01
    10 x 69.00
    -
    0.50
    0.72%
    SPY
    390.56
    +0.93 (0.24%)
    SPDR S&P 500 ETF Trust
    389.63
    12 @ 04:00 PM
    14 x 390.38
    9 x 390.70
    +
    0.17
    0.04%
    TQQQ
    27.38
    +0.04 (0.15%)
    ProShares UltraPro QQQ
    27.34
    21 @ 04:00 PM
    30 x 27.39
    12 x 27.40
    -
    0.24
    0.87%
    BRK-A
    455000.00
    -1500.00 (0.33%)
    Berkshire Hathaway Inc.
    456500.00
    9 @ 04:00 PM
    9 x 454594.00
    8 x 456875.00
    +
    469.00
    0.10%
    Day Gain
    Gain
    Market Val
    Costs
    Cash
    Portfolio
    Realized
    Dividend
    • Discussion
    • News
    • Summary
    • Signals
    • Financials
    • Alerts
    • Notes
    • Chart
    • Backtest
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • R
      rncolucci last edited by

      Thx for taking my money BCRX ,Bye all for second time. Not looking back again. A sincere GLTA.

      1 Reply Last reply Reply Quote 0
      • R
        rncolucci last edited by

        This is getting really scary at this point

        1 Reply Last reply Reply Quote 0
        • R
          rncolucci last edited by

          This thing is headed to 4.50 so obvious

          1 Reply Last reply Reply Quote 0
          • R
            rncolucci last edited by

            Nice volume

            1 Reply Last reply Reply Quote 0
            • R
              rncolucci last edited by

              If it ever gets over $5 again. I want to exit . Time to really get out of this mess! The people in here worried it might drop to two, that is extremely alarming to me.

              1 Reply Last reply Reply Quote 0
              • R
                rncolucci last edited by

                The Emperor Wears No Clothes

                1 Reply Last reply Reply Quote 0
                • R
                  rncolucci last edited by

                  My own opinion is “The Emperor Wears No Clothes”. This story reminds me of this stock.

                  1 Reply Last reply Reply Quote 0
                  • R
                    rncolucci last edited by

                    Another same old same old. Nothing to see here as usual

                    1 Reply Last reply Reply Quote 0
                    • R
                      rncolucci last edited by

                      Same old same old. Maybe next month. It must be political.

                      1 Reply Last reply Reply Quote 0
                      • R
                        rncolucci last edited by

                        Canceled my latest order. I am back to being negative. Nothing adds up with this stock.

                        1 Reply Last reply Reply Quote 0
                        • R
                          rncolucci last edited by

                          I set a limit at 4.95

                          1 Reply Last reply Reply Quote 0
                          • R
                            rncolucci last edited by

                            @Biotech is Boomin, can you dumb it down for me , what you just posted, is it bad news, as in holding might not be a good idea? Yes, I am admitting I do not understand the terms you use. Ty for any anticipated reply.

                            1 Reply Last reply Reply Quote 0
                            • R
                              rncolucci last edited by

                              8 monthes? Is that the time frame? Please tell me it will be sooner?

                              1 Reply Last reply Reply Quote 0
                              • R
                                rncolucci last edited by

                                Thank you Ken for your kindness. Have a great night

                                1 Reply Last reply Reply Quote 0
                                • R
                                  rncolucci last edited by

                                  Could kick myself for getting back in this, nothing will change. False hope is all this is.

                                  1 Reply Last reply Reply Quote 0
                                  • R
                                    rncolucci last edited by

                                    5.05 seems to be its favorite number today.

                                    1 Reply Last reply Reply Quote 0
                                    • R
                                      rncolucci last edited by

                                      Please let there be a possible buyout. Why won’t this thing blank or get off the pot already?

                                      1 Reply Last reply Reply Quote 0
                                      • R
                                        rncolucci last edited by

                                        And here it comes, fishing time, so predictable

                                        1 Reply Last reply Reply Quote 0
                                        • R
                                          rncolucci last edited by

                                          All biotech stocks are going up but here we are with this one. I wish I had something positive to say.

                                          1 Reply Last reply Reply Quote 0
                                          • R
                                            rncolucci last edited by

                                            No news on BCRX , I will not add but will play ones with news today.

                                            1 Reply Last reply Reply Quote 0
                                            • 1
                                            • 2
                                            • 3
                                            • 4
                                            • 5
                                            • 18
                                            • 19
                                            • 1 / 19
                                            • First post
                                              Last post
                                            Profile ...
                                            BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
                                            Earning ...
                                            Date For Estimate Reported Surprise surprise %
                                            2022-05-05 2022-03 -0.39 -0.4 -0.01 -2.56%
                                            2022-02-23 2021-12 -0.31 -0.4 -0.09 -29.03%
                                            2021-11-03 2021-09 -0.3 -0.33 -0.03 -10.00%
                                            2021-08-05 2021-06 -0.22 -0.24 -0.02 -9.09%
                                            2021-05-06 2021-03 -0.26 -0.36 -0.1 -38.46%
                                            2021-02-25 2020-12 -0.25 -0.34 -0.09 -36.00%
                                            Upgrade / Downgrade ...
                                            Date Firm Action From To
                                            2022-04-18 Barclays Downgrade Overweight Equal-Weight
                                            2022-04-12 RBC Capital Upgrade Sector Perform
                                            2022-04-11 B of A Securities Downgrade Buy Neutral
                                            2022-04-11 Oppenheimer Upgrade Outperform
                                            2021-12-10 Oppenheimer Upgrade Outperform
                                            2021-11-04 RBC Capital Upgrade Sector Perform
                                            Insider Holder ...
                                            Date Name Relation Quantity Description
                                            2022-04-17 ABERCROMBIE GEORGE B Director 0.00 Sale
                                            2022-02-27 ASELAGE STEPHEN J Director 33.16K Stock Award(Grant)
                                            2022-03-06 BABU YARLAGADDA S Officer 230.06K Sale
                                            2022-02-27 HEGGIE THERESA Director 16.23K Stock Award(Grant)
                                            2022-02-27 INGRAM ROBERT ALEXANDER Director 80.06K Stock Award(Grant)
                                            2022-02-28 JONES MICHAEL L. Officer 11.20K Sale
                                            Institution Ownership ...
                                            Report Date Organization Position Value Percentage
                                            2022-03-30 Blackrock Inc. 14.10M 229.30M 7.60%
                                            2022-03-30 Vanguard Group, Inc. (The) 13.21M 214.75M 7.12%
                                            2022-03-30 Baker Brothers Advisors, LLC 12.71M 206.68M 6.85%
                                            2022-03-30 FMR, LLC 8.41M 136.82M 4.53%
                                            2022-03-30 State Street Corporation 7.46M 121.34M 4.02%
                                            2022-03-30 Pictet Asset Management SA 5.11M 83.04M 2.75%
                                            Fund Ownership ...
                                            Report Date Organization Position Value Percentage
                                            2022-01-30 SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 5.30M 81.83M 2.85%
                                            2021-12-30 Vanguard Total Stock Market Index Fund 5.11M 70.78M 2.75%
                                            2022-01-30 iShares Russell 2000 ETF 4.13M 63.78M 2.22%
                                            2022-02-27 Fidelity Select Portfolios - Biotechnology 2.85M 47.28M 1.53%
                                            2021-12-30 Vanguard Extended Market Index Fund 2.41M 33.40M 1.30%
                                            2021-12-30 Artisan International Small-Mid Fund 1.89M 26.13M 1.02%
                                            Dividend ...
                                            Dividend Date
                                            0 2014-06-11
                                            0 2014-06-05
                                            0 2014-05-20
                                            0 2014-05-16
                                            0 2014-04-02
                                            Copyright © 2022 finabase.io